Preissner, Robert

The target landscape of clinical kinase drugs

Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P.-A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., et al. (2017) · Science

Computational Drug Discovery MethodsAdvanced Proteomics Techniques and Applications

Cited by 854

SuperTarget and Matador: resources for exploring drug-target relationships

Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research

Computational Drug Discovery MethodsBiomedical Text Mining and Ontologies

Cited by 647

WITHDRAWN—a resource for withdrawn and discontinued drugs

Siramshetty, V. B., Nickel, J., Omieczynski, C., Gohlke, B.-O., Drwal, M. N., & Preissner, R. (2016) · Nucleic Acids Research

Pharmacovigilance and Adverse Drug ReactionsComputational Drug Discovery Methods

Cited by 286

Computational methods for prediction of in vitro effects of new chemical structures

Banerjee, P., Siramshetty, V. B., Drwal, M. N., & Preissner, R. (2016) · Journal of Cheminformatics

Computational Drug Discovery MethodsAnimal testing and alternatives

Cited by 60

Esketamine combined with SSRI or SNRI for treatment-resistant depression

Del Casale, A., Spirito, S., Arena, J. F., Preissner, S., Borro, M., Gentile, G., Modesti, M. N., Preissner, R., Ferracuti, S., & Simmaco, M. (2025) · JAMA Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 23

Personalized Cancer Therapy Considering Cytochrome P450 Variability

Preissner, S., Simmaco, M., Gentile, G., & Preissner, R. (2015) · Advances in Pharmacology

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 12